For the Inventor, By the Inventor

Enter assignee name

Notting Hill, Australia

Biota Scientific Management Pty Ltd

Calculating rank

USPTO Granted Patents = 54

% Expired Patents = 55.6

EPO Patents = 13

Forward Citations = 887

Loading Chart...

Loading Chart...

94 inventors (with patents filed for the assignee):

Alistair George Draffan (14 out of 15 patents)

Wen-Yang Wu (13 out of 14 patents)

Keith G Watson (13 out of 61 patents)

4. Darryl McConnell (11 out of 23 patents)

5. Betty Jin (11 out of 15 patents)

6. Guy Y Krippner (11 out of 15 patents)

7. Silas Bond (9 out of 10 patents)

8. Penelope Anne Mayes (7 out of 7 patents)

9. Pauline Stanislawski (7 out of 7 patents)

10. Jeffrey Peter Mitchell (7 out of 9 patents)

11. Simon J F MacDonald (7 out of 7 patents)

12. Stephen E Shanahan (7 out of 7 patents)

13. Michael Harding (6 out of 7 patents)

14. Derek Anthony Demaine (5 out of 6 patents)

15. Marija Prhavc (4 out of 20 patents)

Core Competencies:

Polycyclic Agents

Viral Polymerase Inhibitors

Bicyclic Nucleosides

Antiviral Agents

Neuraminidase Inhibitors

Dimeric Compounds

Substituted Imidazopyrrolopyrazines

Enterovirus Treatment

Nucleotide Mimics

Antibacterial Agents

Crystalline Derivatives

Dihydropyran Derivatives

54 patents: Sort by Forward Citations

1. 9675694 - Polycyclic agents for the treatment of respiratory syncytial virus infections (2017-06-13),

2. 9540387 - Substituted imidazo[1,2-d]pyrrolo[1,2-d]pyrazines for treating respiratory syncytial virus infections (2017-01-10),

3. 9447080 - Viral polymerase inhibitors (2016-09-20),

4. 9359377 - Substituted imidazo[1,2-a]imidazo[4',5′:4,5]pyrrolo[1,2-d]pyrazines for treating respiratory syncytial virus infections (2016-06-07),

5. 9303026 - Antiviral agents (2016-04-05),

6. 9206171 - 6-{2 -[1-(6-methyl-3-pyridazinyl)-4-piperidinyl]ethoxy}-3-ethoxy-1,2-benzisoxazole bis-dihydrogenphosphate salt (1:2) (2015-12-08),

7. 9163029 - Substituted imidazo[1,2-a]pyrrolo[1,2-d]pyrazines for treating respiratory syncytial virus infections (2015-10-20),

8. 9120775 - Viral polymerase inhibitors (2015-09-01),

9. 8802840 - Bicyclic nucleosides and nucleotides as therapeutic agents (2014-08-12),

10. 8796303 - Imidazo[2,1-G][1,7]naphthyridines for treating respiratory syncytial virus infections (2014-08-05),

11. 8796273 - Compound for the treatment of enteroviruses (2014-08-05),

12. 8785478 - Viral polymerase inhibitors (2014-07-22),

13. 8624025 - Antiviral agents (2014-01-07),

14. 8604034 - [object Object] (2013-12-10),

15. 8598194 - Polycyclic agents for the treatment of respiratory syncytial virus infections (2013-12-03),

Company Overview

Biota Scientific Management Pty Ltd, based in Notting Hill, Australia, specializes in the development of antiviral agents targeting various viral infections. The company focuses on innovative therapeutic solutions, particularly in the realm of polycyclic agents and viral polymerase inhibitors. Its research encompasses a range of advanced compounds, including bicyclic nucleosides and neuraminidase inhibitors, aimed at enhancing treatment options for enterovirus and other viral diseases. Biota's commitment to antiviral research positions it as a key player in the pharmaceutical landscape.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

54 Patents

#2 in Notting Hill

#57 in Australia

#13,146 in the World

Notting Hill, Australia

Biota Scientific Management Pty Ltd

Forward Citations = 887

94 inventors:

Alistair George Draffan (14 out of 15 patents)

Wen-Yang Wu (13 out of 14 patents)

Keith G Watson (13 out of 61 patents)

4. Darryl McConnell (11 out of 23 patents)

5. Betty Jin (11 out of 15 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Biota Scientific Management Pty Ltd. Retrieved from https://idiyas.com/company/biota-scientific-management-pty

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…